These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 19040011)
1. [With advantage or disadvantage? The controversy on polarized fluid has come to a conclusion in the end]. Huang J Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(26):1801. PubMed ID: 19040011 [No Abstract] [Full Text] [Related]
2. Glucose-insulin-potassium therapy in patients with STEMI. Chaudhuri A; Nesto R; Dandona P JAMA; 2008 May; 299(20):2386-7; author reply 2387-8. PubMed ID: 18505943 [No Abstract] [Full Text] [Related]
3. Glucose-insulin-potassium therapy in patients with STEMI. Selker HP; Ingwall J; Rackley CE JAMA; 2008 May; 299(20):2385; author reply 2387-8. PubMed ID: 18505942 [No Abstract] [Full Text] [Related]
4. Glucose-insulin-potassium therapy in patients with STEMI. Arora RR; Katragadda S JAMA; 2008 May; 299(20):2386; author reply 2387-8. PubMed ID: 18505944 [No Abstract] [Full Text] [Related]
5. Management of blood glucose in patients with acute coronary syndromes. Lipska KJ; Kosiborod M Rev Cardiovasc Med; 2012; 13(2-3):e77-88. PubMed ID: 23160165 [TBL] [Abstract][Full Text] [Related]
6. [Is justified the use of GIK solutions in acute myocardial infarct?]. de Micheli A Arch Cardiol Mex; 2008; 78(3):243-6. PubMed ID: 18959010 [No Abstract] [Full Text] [Related]
7. Effects of glucose-insulin-potassium solution on acute myocardial infarction outcome in patients received streptokinase according to Killip classes. Soltani Z; Samadikhah J; Azarfarin R; Hashemi B; Nezami N Anadolu Kardiyol Derg; 2010 Aug; 10(4):372-5. PubMed ID: 20693135 [No Abstract] [Full Text] [Related]
8. [Effect of high dose glucose-insulin-potassium infusion in patients with acute ST-segment elevation myocardial infarction: analysis of 7510 patients in China as part of CREATE-ECLA study]. Yang YM; Zhu J; Tan HQ; Liang Y; Zhang Y; Li Y; Li JD; Liu LS; Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(26):1806-10. PubMed ID: 19040013 [TBL] [Abstract][Full Text] [Related]
9. Glucose-insulin-potassium infusion and mortality in the CREATE-ECLA trial. Apstein CS JAMA; 2005 Jun; 293(21):2596-7; author reply 2598. PubMed ID: 15928276 [No Abstract] [Full Text] [Related]
10. Glucose-insulin-potassium infusion and mortality in the CREATE-ECLA trial. Dey J; Blonde L; Burshell A; Bolton P; Richard A JAMA; 2005 Jun; 293(21):2597-8; author reply 2598. PubMed ID: 15928277 [No Abstract] [Full Text] [Related]
13. Glucose, insulin, and acute myocardial infarction. Das UN Eur Heart J; 2006 Sep; 27(17):2141-2; author reply 2142-3. PubMed ID: 16908489 [No Abstract] [Full Text] [Related]
14. Efficacy of intravenous polarizing solutions: the effect of intracellular potassium concentration and transmembrane potential in clinical patients. Burchett GD J Am Osteopath Assoc; 1968 Oct; 68(2):174-9. PubMed ID: 5188544 [No Abstract] [Full Text] [Related]
15. Supraphysiological levels of magnesium in cardioplegic arrest solutions: is there cause for concern? Tyers GF Can J Cardiol; 1995 Jan; 11(1):21-2. PubMed ID: 7850660 [No Abstract] [Full Text] [Related]